GlassScriptPhysician profile
Gunwant K Guron
NPI 1417926429
$12,200.39
in general payments reported to CMS, 2019-2025
62 companies · $2,117 in 2025
The $2,117 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,529 · 2020: $448 · 2021: $1,596 · 2022: $1,641 · 2023: $1,706 · 2024: $3,164 · 2025: $2,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,853 · Long Term Medical Supply Or Device Loan: $997 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,852.78 |
| Long Term Medical Supply Or Device Loan | $997.00 |
| Education | $137.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,715.70 | 2019-2025 | |
| Incyte Corporation | $1,211.45 | 2019-2025 | Jakafi |
| Astrazeneca Pharmaceuticals LP | $1,057.72 | 2019-2025 | Enhertu, Tezspire, Lynparza |
| Genzyme Corporation | $857.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $697.28 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Janssen Biotech, INC. | $631.41 | 2019-2025 | Talvey, Darzalex, Tecvayli |
| Pfizer INC. | $580.41 | 2019-2025 | |
| Daiichi Sankyo INC. | $508.07 | 2019-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $490.53 | 2019-2025 | |
| Amgen INC. | $454.66 | 2019-2023 | Lumakras, Nplate, Xgeva |
| Gilead Sciences, INC. | $386.25 | 2019-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $282.82 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Merck Sharp & Dohme LLC | $273.84 | 2019-2025 | Keytruda, Lynparza |
| Lilly USA, LLC | $256.87 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $239.49 | 2019-2025 | Iclusig, Alunbrig, Ninlaro |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $219.72 | 2019-2025 | Hemlibra, Venclexta |
| Cti Biopharma Corp. | $205.66 | 2022-2023 | Vonjo |
| Celgene Corporation | $137.69 | 2019-2024 | Opdualag, Pomalyst |
| Sobi, INC | $135.92 | 2022-2025 | |
| Taiho Oncology, INC. | $131.05 | 2019-2025 | |
| Rigel Pharmaceuticals, INC. | $127.12 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Csl Behring | $114.56 | 2019-2024 | Hemgenix |
| Janssen Pharmaceuticals, INC | $106.10 | 2019-2025 | Erleada |
| Octapharma USA, INC. | $94.71 | 2019-2024 | Octagam Immune Globulin (Human) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.04 | 2019-2022 | |
| Eisai INC. | $84.80 | 2019-2023 | |
| Pharmaessentia USA Corporation | $68.88 | 2024-2025 | Besremi |
| Seagen INC. | $63.85 | 2019-2023 | Adcetris, Padcev |
| Agios Pharmaceuticals, INC. | $57.06 | 2024-2025 | Pyrukynd |
| Global Blood Therapeutics, INC. | $56.73 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $54.96 | 2023 | Empaveli |
| Exelixis INC. | $48.83 | 2023-2025 | Cabometyx |
| Stemline Therapeutics INC. | $48.77 | 2025 | Orserdu |
| Emmaus Medical, INC. | $48.00 | 2022-2024 | Endari |
| Array Biopharma INC | $47.72 | 2023-2025 | Lorbrena, Braftovi, Mektovi |
| Astellas Pharma US INC | $46.21 | 2019-2025 | Xtandi |
| Alexion Pharmaceuticals, INC. | $45.06 | 2019-2025 | Ultomiris |
| Pharmacosmos Therapeutics INC. | $38.74 | 2023 | Monoferric |
| Servier Pharmaceuticals LLC | $34.53 | 2023-2025 | |
| Geron Corporation | $32.48 | 2025 | Rytelo |
| Bio Products Laboratory USA, INC. | $31.89 | 2022 | |
| Mirati Therapeutics, INC. | $31.16 | 2023 | Krazati |
| Tempus Ai, INC | $29.94 | 2024 | |
| Bioverativ Therapeutics INC. | $28.89 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.00 | 2020 | |
| Puma Biotechnology, INC. | $24.17 | 2020 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Beone Medicines USA, INC. | $21.66 | 2025 | Tevimbra |
| Siemens Medical Solutions USA, INC. | $19.27 | 2025 | Automated Blood Coagulation Analyzer Cs-5100 |
| Aveo Pharmaceuticals, INC. | $18.48 | 2022 | |
| Karyopharm Therapeutics INC. | $18.09 | 2025 | Xpovio |
| Macrogenics, INC. | $17.68 | 2022 | |
| Deciphera Pharmaceuticals INC. | $17.30 | 2023 | Qinlock |
| Azurity Pharmaceuticals, INC. | $17.14 | 2025 | Danziten |
| Immunogen, INC. | $14.93 | 2023 | Elahere |
| Tesaro, INC. | $14.16 | 2019 | |
| Biomarin Pharmaceutical INC. | $14.10 | 2024 | Roctavian |
| Dova Pharmaceuticals | $13.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.06 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.13 | 2019 | |
| Kite Pharma, INC. | $10.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gunwant Guron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.